Application of ilioabdominal / ilioinguinal nerve block combined with transverse abdominal fascia block in cesarean section of patients with neurofibromatosis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038882

Enrollment

Unknown

Registered

2020-10-08

Start date

2020-11-01

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe obstetric

Interventions

experimental group:nerve block

control group:no intervention

Eligibility

Sex/Gender

Female

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women aged 18-40 with neurofibromatosis; 2. Subjects with gestational age of 32 weeks or more; 3. The subjects who planned to undergo cesarean section after bilateral ihinb combined with bilateral tapb under ultrasound guidance.

Exclusion criteria

Exclusion criteria: 1. Emergency operation; 2. The patient refused to participate; 3. Subjects with hypertension, coronary heart disease or diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
respiratory rate;non-invasive blood pressure;oxygen saturation;visual analogue scale;nausea and vomiting;	—

Countries

China

Contacts

Public ContactZhang Xiaojun

Qilu Hospital of Shandong University

sduzhangxiaojun@163.com+86 15953143883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026